Stock Scorecard

Stock Summary for Purple Biotech Ltd (PPBT) - $0.57 as of 10/8/2025 4:31:51 PM EST

Total Score

10 out of 30

Safety Score

16 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PPBT

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PPBT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PPBT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PPBT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PPBT (16 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for PPBT

Company Overview
Ticker PPBT
Company Name Purple Biotech Ltd
Country USA
Description Purple Biotech Ltd. is a clinical-stage pharmaceutical company based in Rehovot, Israel, dedicated to the development and commercialization of innovative therapeutic agents targeting cancer treatment. With a strong portfolio of drug candidates, the company leverages advanced research methodologies to address significant unmet medical needs in oncology. Purple Biotech aims to enhance patient outcomes through its focus on precision medicine and novel treatment approaches, positioning itself as a key player in the biopharmaceutical landscape.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 6/30/2025
Next Earnings Date 11/13/2025

Stock Price History
Last Day Price 0.57
Price 4 Years Ago 77.80
Last Day Price Updated 10/8/2025 4:31:51 PM EST
Last Day Volume 232,338
Average Daily Volume 2,038,732
52-Week High 8.40
52-Week Low 0.53
Last Price to 52 Week Low 7.55%

Valuation Measures
Trailing PE N/A
Industry PE 22.22
Sector PE 41.70
5-Year Average PE -45.68
Free Cash Flow Ratio 1.10
Industry Free Cash Flow Ratio 14.45
Sector Free Cash Flow Ratio 30.25
Current Ratio Most Recent Quarter 2.88
Total Cash Per Share 0.52
Book Value Per Share Most Recent Quarter 0.06
Price to Book Ratio 0.16
Industry Price to Book Ratio 29.58
Sector Price to Book Ratio 32.02
Price to Sales Ratio Twelve Trailing Months 58.08
Industry Price to Sales Ratio Twelve Trailing Months 44.16
Sector Price to Sales Ratio Twelve Trailing Months 20.22
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 9,030,400
Market Capitalization 5,147,328
Institutional Ownership 4.11%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -36,318.51%
Reported EPS 12 Trailing Months -45.90
Reported EPS Past Year -0.57
Reported EPS Prior Year -1.87
Net Income Twelve Trailing Months -2,611,000
Net Income Past Year -7,240,000
Net Income Prior Year -19,880
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth -100.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 4,736,000
Total Cash Past Year 7,401,000
Total Cash Prior Year 14,489,000
Net Cash Position Most Recent Quarter 4,736,000
Net Cash Position Past Year 7,401,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 32,860,000
Total Stockholder Equity Prior Year 34,207,000
Total Stockholder Equity Most Recent Quarter 32,005,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -10,785,011
Free Cash Flow Per Share Twelve Trailing Months -1.19
Free Cash Flow Past Year -14,367,000
Free Cash Flow Prior Year -19,928,000

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta -0.84
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System
Modified 10/7/2025 7:26:54 AM EST